HIGHLIGHTS
- who: Kyu Sic You et al. from the Department of Biochemistry, College of Medicine, Dankook University have published the paper: Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer, in the Journal: Pharmaceuticals 2021, 14, 589. of December/23,/2020
- what: In this review the authors analyzed the literature on the combination of EGFRis with other molecularly targeted therapeutics or conventional chemotherapeutics to understand the current knowledge and to provide potential therapeutic options for TNBC treatment. The authors provide a brief overview of cancer resistance to anti-EGFR therapies, especially . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.